Category Archives: Featured

Conversations, Featured

Community and Impact on Clinically Vulnerable Patients

CPSA Everyday Conversation

Sigrid Deprez, Ghent University; Dan Baker, University of Hertfordshire; Nithya Paranthama, The Institute of Cancer Research

“If we succeed we can change people’s life” – Sigrid Deprez, Ghent University

“Because it samples in a different way, it opens up applications that are quite unique and quite interesting” – Dan Baker, University of Hertfordshire

“The pandemic has definitely given us the opportunity to innovate” – Nithya Paranthama, The Institute of Cancer Research

Sigrid Deprez, Dan Baker and Nithya Paranthama team up to deliver a passionate CPSA Everyday focussing on how microsampling can help patient populations – especially with the difficulties during the pandemic.  Sigrid discusses how remote microsampling can help immunosuppressed patients, and those that may need treatments in remote places.  Dan Baker looks to continue development of microsampling technologies, with known challenges – but knowing that we will be able to sample patients more often, for increased knowledge for making decisions in treatments.  Nithya Paranthama interacts with cancer patients and sees first hand the struggles and difficulties families and individuals are going through – especially during the pandemic.  She describes a shift to telemedicine and a future that relives stresses when going through a cancer treatment.  This intimate CPSA Everyday describes a future vision that truly places the patient at the centre of the conversation.  

Conversations, Featured, Patient Centric, Portable, Regulatory, Solutions

Microsampling Is Well Established. Now It’s Just A Matter of How We Implement It!

23rd Clinical & Pharmaceutical Solutions through Analysis USA (CPSA USA 2020)

Pre-Conference Workshop – Microsampling

Sponsored by New Objective

Enaksha Wickremsinhe, Eli Lilly & Co.

“Easy to understand unhealthy, how do we understand healthy?” – Enaksha Wickremsinhe, Eli Lilly & Co.

Microsampling in patients is already an established method, but how do we increase adoption and integrate into current workflows?  Enaksha talks about how we are all patients, and that we all have or will ride the healthcare train.  Our goal is to stay healthy, but often we only visit the doctor’s office when we are sick.  Enaksha describes a world where microsampling plays an important role in describing health – possibly sampling at home – instead of only going to the clinic or doctor’s office when we are sick.  Ubiquitously implementing these new processes using existing, mature technologies has gained momentum – but it has and does take a village to get it done.

Conversations, Featured, Microsampling, Patient Centric, Portable, Solutions

Microsampling: Can We Use Technology in Healthcare? It Is Time To Push For These Changes

23rd Clinical & Pharmaceutical Solutions through Analysis USA (CPSA USA 2020)

Pre-Conference Workshop – Microsampling

Sponsored by New Objective

Melanie Anderson, Merck

“Focus on the North Star, the patient” – Melanie Anderson, Merck

Melanie is focused on the patient and how to improve healthcare, through microsampling techniques and improved clinical trial data.  With the onset of the pandemic, we have had to rethink the way we practice healthcare and clinical trials, especially those that are at high risk, i.e. sick children and oncology patients.  Melanie suggests that we can improve patient care through remote sampling, alleviating the need to travel to a medical center – even long distances – to participate in clinical trials.  As well, pharma makes decisions based on data, so improvements in data will lead to better decisions.  With all of the technology that we have already, why do we think of and implement different ways to move forward with healthcare and clinical trials?